Adagene, Inc. (ADAG)
3.17
+0.20
(+6.73%)
USD |
NASDAQ |
Sep 16, 16:00
3.16
-0.01
(-0.32%)
After-Hours: 20:00
Adagene Price : 3.17 for Sept. 16, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | 3.00 | 3.237 | 2.92 | 3.17 | 319282.0 |
| Sep 15, 2026 | 3.385 | 3.385 | 2.925 | 2.97 | 626154.0 |
| Sep 14, 2026 | 3.38 | 3.60 | 3.235 | 3.27 | 155084.0 |
| Sep 11, 2026 | 3.36 | 3.48 | 3.238 | 3.40 | 258867.0 |
| Sep 10, 2026 | 3.54 | 3.552 | 3.20 | 3.31 | 224590.0 |
| Sep 09, 2026 | 3.61 | 3.69 | 3.24 | 3.27 | 267527.0 |
| Sep 08, 2026 | 3.55 | 3.61 | 3.45 | 3.49 | 193001.0 |
| Sep 04, 2026 | 3.67 | 3.692 | 3.56 | 3.58 | 28194.00 |
| Sep 03, 2026 | 3.71 | 3.85 | 3.56 | 3.69 | 167713.0 |
| Sep 02, 2026 | 3.60 | 3.74 | 3.600 | 3.69 | 102670.0 |
| Sep 01, 2026 | 3.51 | 3.675 | 3.42 | 3.64 | 120551.0 |
| Aug 31, 2026 | 3.62 | 3.62 | 3.451 | 3.51 | 131615.0 |
| Aug 28, 2026 | 3.89 | 3.89 | 3.66 | 3.68 | 123153.0 |
| Aug 27, 2026 | 3.85 | 3.97 | 3.71 | 3.90 | 296251.0 |
| Aug 26, 2026 | 3.97 | 4.09 | 3.82 | 3.85 | 122149.0 |
| Aug 25, 2026 | 3.90 | 3.97 | 3.80 | 3.82 | 63073.00 |
| Aug 24, 2026 | 3.99 | 4.005 | 3.795 | 3.90 | 159181.0 |
| Aug 21, 2026 | 4.11 | 4.115 | 3.97 | 4.02 | 61307.00 |
| Aug 20, 2026 | 4.11 | 4.18 | 4.01 | 4.09 | 205032.0 |
| Aug 19, 2026 | 4.11 | 4.190 | 4.00 | 4.12 | 278433.0 |
| Aug 18, 2026 | 3.81 | 4.19 | 3.78 | 4.05 | 332572.0 |
| Aug 17, 2026 | 3.63 | 3.99 | 3.59 | 3.83 | 1.053M |
| Aug 14, 2026 | 3.75 | 3.825 | 3.58 | 3.70 | 152276.0 |
| Aug 13, 2026 | 3.77 | 3.91 | 3.652 | 3.72 | 123294.0 |
| Aug 12, 2026 | 4.04 | 4.239 | 3.71 | 3.75 | 294443.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 1.10 |
| CStone Pharmaceuticals Co. Ltd. | 0.9109 |
| RemeGen Co., Ltd. | 10.93 |
| InnoCare Pharma Ltd. | 1.55 |
| JW (Cayman) Therapeutics Co. Ltd. | 0.2022 |
Price Related Metrics
| PS Ratio | 17.69 |
| Earnings Yield | -11.91% |
| Market Cap | 212.84M |